Key Personnel

Senior Management Team

• Michael J. O'Brien, President and CEO, has held various senior management positions in the healthcare industry, including experience with biopharmaceutical and medical device companies. Since 1993, he has held Vice President and CFO positions with Bionx Implants, a publicly held medical device company, Biosyn Inc., a biotechnology company, and Biocyte Corporation, a biotechnology company engaged in stem cell transplantation. From 1986 to 1993, he held senior finance and operations positions, domestically and abroad, with the Allerion Corporation, a high technology computer company. He began his career as an auditor with the accounting firm of Deloitte & Touche as a certified public accountant, and graduated from Villanova University in 1983.

• Donna E. Beardsworth, MA, Executive Vice President and Chief Delivery Officer, brings over 24 years of clinical research experience including 'hands-on' in-clinic responsibilities and clinical project and personnel management to her position. She has worked at the investigative site level, the sponsor level, and at the CRO level in all aspects of clinical drug development processes. Her experience in clinical research affords an incomparable vantage point from which to assess and develop clinical research practices. Donna is uniquely qualified to bring a unity of vision to the conduct and management of outsourced clinical trial functions. Donna heads both the Executive and the Senior Management Teams at Beardsworth and is the Chair of the Advisory Board. Donna was named Entrepreneur of the Year in 2002 by the Hunterdon County Chamber of Commerce and is a past President of the NNJ-ACRP Chapter where she currently serves as a trustee.

• Vincent F. DiBianca , a Beardsworth Principal, serves on the Executive Management Team and Advisory Board. Vince brings over 35 years of diverse international business experience. He was a partner at Touche Ross, now Deloitte & Touche, from 1969 to 1983, when he left to start a management consulting firm, The DiBianca Berkman Group. He has provided management consulting services to the leaders of many of the world’s largest organizations including, the CEOs of Warner-Lambert, Sears, Hughes Aircraft, Reebok, Allstate and a variety of smaller and start-up organizations. In the pharmaceutical industry, his focus was on implementing high-level strategy, developing senior teams and accelerating drug development projects. Beginning in 1983, Vince was responsible for building his own consulting firm up to 50 professionals until it was acquired by Computer Sciences Corporation (CSC) in 1993. He served on the Executive Team of CSC’s consulting group through 1999, when he left to focus on working with smaller companies and individual entrepreneurs. An author of numerous articles on leadership and change and featured in Newsweek, Fortune, Industry Week and The Wall Street Journal, Vince is currently co-authoring a book entitled, The Second Half of Life.

• Art Gertel, Vice President, Strategic Regulatory Consulting, Medical Writing, & QA, has more than 25 years of experience in the pharmaceutical industry. Art has had a broad range of primarily management-level responsibility in virtually all phases of pharmaceutical drug research and development, from preclinical pathology/toxicology to registrational clinical trials, post-marketing trials, project management, and market support. His most recent experiences include directing the Medical Communications Department at Schering-Plough, with responsibility for preparing all new drug applications, worldwide; and heading the Project and Portfolio Management functions of the Advanced Phase (Phases IIIb and IV) group at Quintiles. In addition, he recently headed the clinical trials operations at iKnowMed, with the charge of applying the company’s electronic data capture technology to pharmaceutical clinical trials. He received undergraduate education in Biology and Psychology at the University of Pennsylvania and pursued graduate studies in Behavioral Medicine at New York Medical College, and Pharmaceutics at Temple University. He served as President of the American Medical Writers Association (AMWA): a biomedical communications professional association comprising more than 4,000 members, worldwide. He is a frequent lecturer and teacher at Drug Information Association (DIA), European Medical Writers Association (EMWA) and AMWA meetings and is very active in the Clinical Data Interchange Standards Consortium (CDISC) efforts to standardize clinical data. Art is a Fellow of AMWA and EMWA.

• Linda Diehl Martz, RN is a Project Director at Beardsworth and the Executive Director of Data Management. Linda oversees the planning, management and delivery of clinical projects and functions as a senior-level contact to clients with the goal to bring to clients and BEARDSWORTH project effectiveness. She is also responsible for the entire data management process; her accountability -- ensuring consistency and accuracy of our databases. Linda earned her RN at Somerset County College. She joined Beardsworth in 2000 after 17 years in nursing. Linda's nursing background included service in critical care, the cardiac catheterization lab, and on the transplant team. She also served as a clinical research coordinator. Linda went on to the pharmaceutical industry for 12 years working both in Data Management and Clinical before bringing her expertise to Beardsworth clients.

• Richard Constantine serves on the Executive Management Team and Advisory Board for Beardsworth. He has more than 35 years of experience in Public Accounting, encompassing the For-Profit and Non-Profit sectors and has 25 years of experience consulting in the healthcare industry. After graduating from Villanova University in 1967 he began his career, in Public Accounting, as an auditor with the accounting firm of Deloitte & Touche. In 1972 he started his own accounting practice and maintains that practice until the present.

• J. Richard Trout, PhD is Beardsworth's Senior Biostatistician. His experience includes over 30 years of drug development for FDA approvals. He has established long-term relationships with many FDA statisticians in most divisions of CDER and CBER.

• Jocelyn Colquhoun, PhD is Beardsworth's Director of Medical Writing. Jocelyn brings over 14 years of experience in pharmaceutical clinical research and development, primarily in medical writing. Prior to joining Beardsworth, she was Manager of Medical Writing at Schering-Plough Research Institute with responsibility for preparation of clinical study reports and integrated summaries for Phase II and III studies for eight new drug applications within the allergy and dermatology therapeutic areas. She was also a Director in Project Management at Quintiles, Inc. with responsibility for execution of full-service projects for Phase II to IV studies, including several pediatric dermatology studies for two ‘exclusivity’ submissions to FDA. Jocelyn began her career in the pharmaceutical industry in 1987 at Roberts Pharmaceutical Corporation, where as Manager of Technical Documentation she served as project leader for the company’s first NDA, and held positions of increasing responsibility. She obtained a BA degree from Mount Holyoke College, a PhD in biochemistry from Baylor College of Medicine, and did post-graduate studies in biochemistry at the University of Wisconsin.

• Linda Petrelis, RN is Beardsworth’s Manager of Clinical Data Coordination. Linda brought years of nursing experience to Beardsworth and has developed her clinical data coordination skills at the Company.